NEW class of pain relievers

August 1998

There's a lot of interest in a NEW class of painrelievers...COX-2 specific inhibitors.

Searle's Celebra (celecoxib) will be first...with Merck'sVioxx, and others following.

These will be BIG.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

12 issues every year, with brief articles about new meds and hot topics
300+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Subscription Options

Already a subscriber? Log in

Volume pricing available. Get quote

Table of Contents

Pharmacists in Mississippi will now get paid by the government for pharmaceutical CARE
Gastroenterology New warnings are coming out for Prepulsid (cisapride)
Gastroenterology two TEN-DAY regimens for H. Pylori
Men's Health Viagra is currently the fastest-selling new drug in the U.S. and will be approved in Canada this fall
Men's Health Propecia
Men's Health new drug for benign prostatic hypertrophy, Flomax (tamsulosin)
Cholesterol new 80 mg Zocor (simvastatin) tablet
Cholesterol garlic doesn't reduce cholesterol
Anticoagulants Lovenox (enoxaparin) at HOME
Hypertension new findings are now coming to light regarding drug treatment for hypertension
Hypertension diuretics for the initial treatment of hypertension in the ELDERLY
Hypertension captopril (Capoten) reduces the risk of heart attack, stroke, and death in patients with hypertension
Women's Health Monistat 1, a new one-dose OTC product for vaginal yeast infections
Noni Juice, the "cure-all" made from tropical morinda fruit
Neurology & Pain Duract (bromfenac) was on the U.S. market less than a year
Neurology & Pain NEW class of pain relievers
Multiple Sclerosis Avonex, the new treatment for multiple sclerosis (MS)
Practice the FDA has approved thalidomide (Thalomid) for leprosy